Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.

Background: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastrointestinal perforations caused by bevacizumab are very rare in breast cancer.

Case Presentation: We describe the case of 54-year-old Japanese woman.